The Precision Peptide Genetic Test ($298) can also reveal whether your genetic profile suggests lower tolerance for dual GIP-GLP-1 activation, helping guide your personalized treatment plan
Our clinic is located in Mentor, Ohio, and we serve patients from Cleveland and surrounding Northeast Ohio communities.
Self-harming adverse events in obesity medications are a sensitive issue
Nausea was the most common adverse event (7.8%), and treatment discontinuation occurred in 10.4%, mainly among individuals previously treated with GLP-1 receptor agonists
Personalization, Genetic Insight, and Precision-Medicine Alignment The PlexusDx Precision Peptide Genetic Test analyzes GIPR variants that relate to GLP-1 and related signaling pathways
To view a copy of this licence, visit About this article Cite this article Movahednasab, M., Dianat-Moghadam, H., Khodadad, S